Updated Results from a Phase I/II Study of Duvelisib and Venetoclax in Patients with Relapsed or Refractory CLL/SLL or Richter's SyndromeJennifer L. Crombie, Matthew S. Davids, Jennifer R. Brown et al.|Blood|2020Cited by 14